SPARKS, NV / ACCESSWIRE / January 31, 2024 / Ludwig Enterprises, Inc, (OTC PINK:LUDG): A US-based biotechnology company is pleased to announce that the company has received Continuing Review Approval on its planned clinical study from Advarra IRB, Colu…
Continue ReadingRecipients Receive Awards at 2024 National Mentoring Summit in Washington, D.C.BOSTON, MA / ACCESSWIRE / January 31, 2024 / MENTOR, the nation’s unifying champion of the mentoring movement, has announced the recipients of the annual Excellence in Mento…
Continue ReadingThe World’s Largest Vault of User-Generated Video Lures Roberts from Google to Lead Client Acquisition OperationsLONDON, UK / ACCESSWIRE / January 31, 2024 / Newsflare, the leading provider of user-generated video content for media clients worldwide, h…
Continue ReadingHack The Box raises concerns about the need for a rapid overhaul of recruitment processes and university curricula to solve crippling skills shortages.LONDON, UK / ACCESSWIRE / January 31, 2024 / New research conducted in the UK and US reveals that ove…
Continue ReadingHack The Box raises concerns about the need for a rapid overhaul of recruitment processes and university curricula to solve crippling skills shortages.LONDON, UK / ACCESSWIRE / January 31, 2024 / New research conducted in the UK and US reveals that ove…
Continue ReadingSTOCKHOLM, SWEDEN / ACCESSWIRE / January 31, 2024 / AlzeCure Pharma (STO:ALZCUR)(FRA:AC6) AlzeCure Pharma AB (publ) (FN STO:ALZCUR), a pharmaceutical company that develops candidate drugs for CNS diseases, focusing on Alzheimer’s disease and pain, toda…
Continue ReadingSTOCKHOLM, SWEDEN / ACCESSWIRE / January 31, 2024 / AlzeCure Pharma (STO:ALZCUR)(FRA:AC6) AlzeCure Pharma AB (publ) (FN STO:ALZCUR), a pharmaceutical company that develops candidate drugs for CNS diseases, focusing on Alzheimer’s disease and pain, toda…
Continue Reading